| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |